The deal will boost Cipla's cosmetology portfolio, which has been growing in recent years, according to a report in The Economic Times. Percos India's products are focused upon aging and skin pigmentation.
The deal is being seen as a good marketing strategy on Cipla's part as consumers do not always go for cosmetology products via doctors' prescriptions route. Such products also mostly remain out of the government's price control norms.
Major pointers of the deal:
Cipla had registered Rs 690.05 crore net profit for April-June 2015-16, a rise of 107 per cent over the corresponding quarter of fiscal 2014-15. Total income from operations rose to Rs 3,542.27 crore in the quarter under review from Rs 2,474.46 crore in Q1 2014-15.
Copyright©2022 Living Media India Limited. For reprint rights: Syndications Today